Sign In
Buy CDNA
$38.37
-1.36 (-3.42%)
At Close: Jul 20, 2026
CareDx Announces Proposed Public Offering of Common Stock
09:13pm, Tuesday, 09'th Jun 2020
CareDx also expects to grant the underwriters of the offering a 30-day option to purchase up to an additional $15.0 million of shares of its common stock offered in the public offering on the same ter
Seven Bridges Selected by CareDx to Advance Its Transplant Care Solutions
12:00pm, Tuesday, 09'th Jun 2020
Seven Bridges, the industry-leading bioinformatics ecosystem provider, announced today a new partnership with CareDx, Inc. (Nasdaq: CDNA) supporting the CareDx AlloSure 3.0 workflow. CareDx is a leadi
CareDx Announces 2020 Annual Meeting of Stockholders to be Held as a Virtual Meeting
09:00pm, Monday, 08'th Jun 2020
Due to conditions associated with the impact of the Coronavirus pandemic (COVID-19), including restrictions on in-person gatherings, and in order to support the health and well-being of our stockholde
Citigroup Inc. Acquires 41,867 Shares of CareDx Inc (NASDAQ:CDNA)
08:04am, Sunday, 07'th Jun 2020
Citigroup Inc. lifted its holdings in shares of CareDx Inc (NASDAQ:CDNA) by 500.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).
State Street Corp Acquires 7,923 Shares of CareDx Inc (NASDAQ:CDNA)
07:20am, Sunday, 07'th Jun 2020
State Street Corp increased its holdings in CareDx Inc (NASDAQ:CDNA) by 0.3% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commissio
CareDx to Participate at the Goldman Sachs Global Healthcare Conference
11:00am, Thursday, 04'th Jun 2020
SOUTH SAN FRANCISCO, Calif., June 04, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of.
CareDx to Present at the Jefferies Virtual Healthcare Conference
11:00am, Thursday, 28'th May 2020
SOUTH SAN FRANCISCO, Calif., May 28, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of.
CareDx Presents the Latest AlloSure Data in Virtual Meetings
11:00am, Wednesday, 27'th May 2020
SOUTH SAN FRANCISCO, Calif., May 27, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of.
CareDx's AlloSeq Tx 17 Awarded CE Mark Approval
11:00am, Friday, 15'th May 2020
SOUTH SAN FRANCISCO, Calif., May 15, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of.
CareDx And Veracyte Announce Exclusive Partnership For Transplant Rejection Testing On nCounter System
12:17pm, Thursday, 14'th May 2020CareDx and Veracyte Announce Exclusive Partnership for Transplant Rejection Testing on nCounter System
12:15pm, Thursday, 14'th May 2020
CareDx and Veracyte Announce Exclusive Partnership for Transplant Rejection Testing on nCounter System
